Drug repurposing for targeting cyclic nucleotide transporters in acute leukemias - A missed opportunity.


:While current treatment regimens for acute leukemia can dramatically improve patient survival, there remains room for improvement. Due to its roles in cell differentiation, cell survival, and apoptotic signaling, modulation of the cyclic AMP (cAMP) pathway has provided a meaningful target in hematological malignancies. Several studies have demonstrated that gene expression profiles associated with increased pro-survival cAMP activity or downregulation of various pro-apoptotic factors associated with the cAMP pathway are apparent in acute leukemia patients. Previous work to increase leukemia cell intracellular cAMP focused on the use of cAMP analogs, stimulating cAMP production via transmembrane-associated adenylyl cyclases, or decreasing cAMP degradation by inhibiting phosphodiesterase activity. However, targeting cyclic nucleotide efflux by ATP-binding cassette (ABC) transporters represents an unexplored approach for modulation of intracellular cyclic nucleotide levels. Preliminary studies have shown that inhibition of cAMP efflux can stimulate leukemia cell differentiation, cell growth arrest, and apoptosis, indicating that targeting cAMP efflux may show promise for future therapeutic development. Furthermore, inhibition of cyclic nucleotide transporter activity may also contribute multiple anticancer benefits by reducing extracellular pro-survival signaling in malignant cells. Hence, several opportunities for drug repurposing may exist for targeting cyclic nucleotide transporters.


Semin Cancer Biol


Perez DR,Sklar LA,Chigaev A,Matlawska-Wasowska K




Has Abstract


2020-02-07 00:00:00








  • Hereditary breast cancer: a review.

    abstract::Breast cancer is the most common female malignancy and a major cause of death in middle-aged women. A positive family history of breast cancer is one of the strongest risk factors for the disease. In addition, many afflicted breast cancer families are characterized by early onset and bilateral tumors, and also, in som...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Arver B,Du Q,Chen J,Luo L,Lindblom A

    更新日期:2000-08-01 00:00:00

  • PIWI-interacting RNAs in human cancer.

    abstract::P-element-induced wimpy testis (PIWI) interacting RNAs (piRNAs) are a class of small regulatory RNAs mechanistically similar to but much less studied than microRNAs and small interfering RNAs. Today the best understood function of piRNAs is transposon control in animal germ cells, which has earned them the name 'guard...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章


    authors: Lin Y,Zheng J,Lin D

    更新日期:2020-09-01 00:00:00

  • Nanotechnology, in silico and endocrine-based strategy for delivering paclitaxel and miRNA: Prospects for the therapeutic management of breast cancer.

    abstract::Breast cancer is one of the most prevalent and reoccurring cancers and the second most common reason of death in women. Despite advancements in therapeutic strategies for breast cancer, early tumor recurrence and metastasis in patients indicate resistance to chemotherapeutic medicines, such as paclitaxel due to the ab...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Ansari MA,Thiruvengadam M,Farooqui Z,Rajakumar G,Sajid Jamal QM,Alzohairy MA,Almatroudi A,Alomary MN,Chung IM,Al-Suhaimi EA

    更新日期:2019-12-28 00:00:00

  • Targeting T cells for GVHD therapy.

    abstract::Bone marrow transplantation is currently used to treat a variety of life-threatening diseases. Its applications could be expanded if the risks of graft-versus-host disease (GVHD), a complex pathologic disease, could be reduced. Immunotoxins may provide a means to control drug refractory GVHD. This article will discuss...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Vallera DA

    更新日期:1996-04-01 00:00:00

  • RAS-mediated oncogenic signaling pathways in human malignancies.

    abstract::Abnormally activated RAS proteins are the main oncogenic driver that governs the functioning of major signaling pathways involved in the initiation and development of human malignancies. Mutations in RAS genes and or its regulators, most frequent in human cancers, are the main force for incessant RAS activation and as...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Khan AQ,Kuttikrishnan S,Siveen KS,Prabhu KS,Shanmugakonar M,Al-Naemi HA,Haris M,Dermime S,Uddin S

    更新日期:2019-02-01 00:00:00

  • Bacterial infection increases risk of carcinogenesis by targeting mitochondria.

    abstract::As up to a fifth of all cancers worldwide, have now been linked to microbial infections, it is essential to understand the carcinogenic nature of the bacterial/host interaction. This paper reviews the bacterial targeting of mediators of mitochondrial genomic fidelity and of mitochondrial apoptotic pathways, and compar...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Strickertsson JAB,Desler C,Rasmussen LJ

    更新日期:2017-12-01 00:00:00

  • Genetic control of the metastatic phenotype.

    abstract::Transfection experiments indicate that a number of genes can induce or suppress the metastatic phenotype. These genes include ten oncogenes, plasminogen activator, and three suppressor genes. The biochemical mechanism(s) whereby each of these genes alters the metastatic phenotype is poorly understood. Hypotheses conce...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Steeg PS

    更新日期:1991-04-01 00:00:00

  • Genomics of gynaecological carcinosarcomas and future treatment options.

    abstract::Gynaecological carcinosarcomas are the most lethal gynaecological malignancies that are often highly resistant to standard chemotherapy. They are composed of both carcinomatous and sarcomatous components and are associated with high rates of metastatic disease. Due to their rarity, molecular studies have been carried ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Barker HE,Scott CL

    更新日期:2020-04-01 00:00:00

  • Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic.

    abstract::Tumor cell invasion is now viewed as dysregulated physiologic invasion. Investigators have started to define the molecular events that are involved in this process. We find that there are many functional similarities with molecular events involved in physiologic process such as angiogenesis and wound healing. Matrix m...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Stetler-Stevenson WG,Hewitt R,Corcoran M

    更新日期:1996-06-01 00:00:00

  • The roles of sirtuins family in cell metabolism during tumor development.

    abstract::Altering energy metabolism to meet the uncontrolled proliferation and metastasis has emerged as one of the most significant hallmarks in tumors. However, the detailed molecular mechanisms and regulatory actions underlying have not been fully elucidated. As a family of NAD+ dependent protein modifying enzymes, sirtuins...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Zhu S,Dong Z,Ke X,Hou J,Zhao E,Zhang K,Wang F,Yang L,Xiang Z,Cui H

    更新日期:2019-08-01 00:00:00

  • KSHV strains: the origins and global spread of the virus.

    abstract::Nucleotide sequence analysis at five distinct loci across the 140, 000 bp genomes of more than 60 KSHV samples from KS and PEL tumors from North America, Africa, the Middle East, Asia and the Pacific revealed that they cluster into four major subtypes (A, B, C and D) that have close associations with the geographic an...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Hayward GS

    更新日期:1999-06-01 00:00:00

  • Oncogene activation and oncogene cooperation in MMTV-induced mouse mammary cancer.

    abstract::In this short review, we will give an overview of the various genes that can be activated by insertion of proviral DNA of the mouse mammary tumor virus during the formation of mammary cancer. These genes fall within three families: Wnt genes, FGF genes and Notch-related genes. We will summarize our current understandi...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: van Leeuwen F,Nusse R

    更新日期:1995-06-01 00:00:00

  • B-cell receptor signaling as a driver of lymphoma development and evolution.

    abstract::The B-cell receptor (BCR) is essential for normal B-cell development and maturation. In an increasing number of B-cell malignancies, BCR signaling is implicated as a pivotal pathway in tumorigenesis. Mechanisms of BCR activation are quite diverse and range from chronic antigenic drive by microbial or viral antigens to...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Niemann CU,Wiestner A

    更新日期:2013-12-01 00:00:00

  • NanoString in the screening of genetic abnormalities associated with thyroid cancer.

    abstract::In the setting of cancer pathology, molecular characterization of tumors providing diagnostic and predictive information is acquiring more and more relevance. Moreover, the advent of innovative technologies continuously improves the knowledge of the molecular landscape of tumors and strengthens the links between clini...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Macerola E,Poma AM,Basolo F

    更新日期:2020-10-19 00:00:00

  • An update on vitamin D signaling and cancer.

    abstract::A low vitamin D status is associated with an increased risk of various cancers, such as of colon, breast, prostate and hematological cells. The biologically most active vitamin D metabolite 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3) is a high affinity ligand of the transcription factor vitamin D receptor (VDR). 1,25(OH)2...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Carlberg C,Muñoz A

    更新日期:2020-05-30 00:00:00

  • Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion.

    abstract::Cells adhere to one another and/or to matrices that surround them. Regulation of cell-cell (intercellular) and cell-matrix adhesion is tightly controlled in normal cells, however, defects in cell adhesion are common in the majority of human cancers. Multilateral communication among tumor cells with the extracellular m...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Bourboulia D,Stetler-Stevenson WG

    更新日期:2010-06-01 00:00:00

  • Repurposing drugs in oncology: From candidate selection to clinical adoption.

    abstract::Drug repurposing is a strategy that aims to develop novel cancer treatments through the reuse of existing medicines developed in other disease areas. Such a strategy includes the identification of candidate drugs, clinical development, drug licensing, reimbursement and clinical implementation. This review outlines a l...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Pantziarka P,Verbaanderd C,Huys I,Bouche G,Meheus L

    更新日期:2020-01-23 00:00:00

  • Stress-activated protein kinases-tumor suppressors or tumor initiators?

    abstract::The biology and the pathology of the stress-activated protein kinases (SAPKs; p38s and c-Jun-NH(2)-terminal kinases (JNKs)) are somewhat confusing. In some systems, these enzymes augment cell proliferation whereas in other cells they support growth arrest and tumor suppressing activity. Similarly, in some types of can...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Engelberg D

    更新日期:2004-08-01 00:00:00

  • The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer.

    abstract::There is sufficient evidence to suggest that tumor growth elicits specific immune responses, including CD8(+) and CD4(+) T cell responses that may delay tumor growth and could potentially be harnessed to eradicate cancer. Nevertheless the frequent outcome of cancer is lethality associated with uncontrolled growth and ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Khazaie K,von Boehmer H

    更新日期:2006-04-01 00:00:00

  • Harnessing serotonergic and dopaminergic pathways for lymphoma therapy: evidence and aspirations.

    abstract::Growing evidence supports the notion that pharmaceutical targeting of the 5-hydroxytryptamine (5-HT) and dopamine (DA) systems offers the potential to treat human immune system disorders. This review describes this emerging area of research, which has the benefit of being supported by a relatively detailed understandi...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Barnes NM,Gordon J

    更新日期:2008-06-01 00:00:00

  • The genomic risk of somatic gene therapy.

    abstract::Gene vectors with an untargeted insertion profile have been explored in preclinical models and clinical trials for the transfer of potentially therapeutic genetic information into somatic cells that have a high replicative potential. The gene-modified cell population can be viewed as a genetic mosaic whose complexity ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Kustikova O,Brugman M,Baum C

    更新日期:2010-08-01 00:00:00

  • Antisense oligonucleotides.

    abstract::Growing evidence indicates that antisense oligodeoxynucleotides can specifically inhibit gene expression thereby providing an essential tool for understanding gene function and the potential to affect abnormal cell proliferation. Because oncogene activation is intimately involved in tumour initiation and progression, ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Calabretta B,Skorski T,Zon G

    更新日期:1992-12-01 00:00:00

  • Molecular mechanistic insights: The emerging role of SOXF transcription factors in tumorigenesis and development.

    abstract::Over the last decade, the development and progress of next-generation sequencers incorporated with classical biochemical analyses have drastically produced novel insights into transcription factors, including Sry-like high-mobility group box (SOX) factors. In addition to their primary functions in binding to and activ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Higashijima Y,Kanki Y

    更新日期:2020-12-01 00:00:00

  • What patents tell us about drug repurposing for cancer: A landscape analysis.

    abstract::Intellectual property documents (patents and their published applications) are not only collections of legal exclusivity claims but also repositories of scientific and technical information, even though they are not peer reviewed. We have identified and analyzed international disclosures concerning drug repurposing fo...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Mucke HAM

    更新日期:2019-09-20 00:00:00

  • Nutrigenomics in cancer: Revisiting the effects of natural compounds.

    abstract::Nutrigenomics effects have an important role in the manipulation of dietary components for human benefit, particularly in cancer prevention or treatment. The impact of dietary components, including phytochemicals, is largely studied by nutrigenomics, looking at the gene expression and molecular mechanisms interacting ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Braicu C,Mehterov N,Vladimirov B,Sarafian V,Nabavi SM,Atanasov AG,Berindan-Neagoe I

    更新日期:2017-10-01 00:00:00

  • Rational drug repurposing for cancer by inclusion of the unbiased molecular dynamics simulation in the structure-based virtual screening approach: Challenges and breakthroughs.

    abstract::Managing cancer is now one of the biggest concerns of health organizations. Many strategies have been developed in drug discovery pipelines to help rectify this problem and two of the best ones are drug repurposing and computational methods. The combination of these approaches can have immense impact on the course of ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Sohraby F,Aryapour H

    更新日期:2020-04-28 00:00:00

  • Definition of tumor antigens suitable for vaccine construction.

    abstract::The treatment of cancer with tumor vaccines has been a goal of physicians and scientists ever since effective immunization against infectious disease with vaccines was developed. In the past, major tumor antigens had not been molecularly characterized. Recent advances are, however, beginning to define potential molecu...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Lewis JJ,Houghton AN

    更新日期:1995-12-01 00:00:00

  • LIM domain proteins in leukaemia and development.

    abstract::T cell acute leukaemias involve a number of different classes of oncogenes. A group of such genes is the RBTN family located on chromosomes 11 and 12. Two members of this family, RBTN1/Ttg-1 and RBTN2/Ttg-2, are located near recurring T cell acute lymphocytic leukaemia-associated translocations. Chromosomal translocat...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Sánchez-García I,Rabbitts TH

    更新日期:1993-12-01 00:00:00

  • Mammary tumorigenesis and metastasis in transgenic mice.

    abstract::The transgenic mouse has emerged as an important model system to assess the transforming potential of oncogenes in the mammary epithelium. Mammary gland-specific expression of oncogenes in transgenic mice has resulted in the induction of a variety of phenotypes ranging from benign epithelial hyperplasias to metastatic...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Webster MA,Muller WJ

    更新日期:1994-02-01 00:00:00

  • Genetic variation and risk of chronic lymphocytic leukaemia.

    abstract::Chronic lymphocytic leukaemia (CLL) is the most common form of lymphoid malignancy in Western countries, accounting for around a quarter of all leukaemias. Evidence from epidemiological and family studies have provided evidence for familial clustering of CLL compatible with inherited genetic predisposition to CLL. Dir...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审


    authors: Crowther-Swanepoel D,Houlston RS

    更新日期:2010-12-01 00:00:00